Paula Terese Trzepacz, M.D. is currently President and CEO of conXiome LLC, a biotech and biopharma consulting firm, and Clinical Professor of Psychiatry at both Indiana University School of Medicine and Tufts Medical School. In 1999 she joined Eli Lilly and company where she worked in Phases 2, 3 and 4 Neurosciences drug development either as an administrative or scientific leader. Dr. Terese Trzepacz has experience in clinical trial design and medical support of global and US submissions and other regulatory agency related work. Trained in psychosomatic medicine, geriatric psychiatry and neuropsychiatry, her focus has been on teaching, clinical care and research for patients with cognitive and neurodegenerative disorders (including dementias, delirium, traumatic brain injury, and ADHD) and the development of clinical tools, drugs and/or biomarkers for these conditions.

Recent Posts

Forward Looking Statements

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements." These forward-looking statements generally are identified by the words believes," project," expects," anticipates," estimates," intends," strategy," plan," may," will," would," will be," will continue," will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

This Blog is official and sanctioned by Amarantus BioScience | See Disclaimer | See Privacy Policy

Get Amarantus BioScience Blog Post Alerts